Klaviyo: Hallen entities sell 98,782 shares
The sale-price footnotes provide individual trading ranges, and the gift went to a donor-advised fund.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Klaviyo, Inc. (KVYO) reported that Hodgkins Trust and Hodgkins LLC sold 98,782 shares on November 5, 2026. The four sales carried weighted-average prices of $21.35 and $20.71 for the trust and $21.52 and $21.07 for the LLC; the transactions were effected under a Rule 10b5-1 trading plan Ed Hallen adopted on June 1, 2026.
Separately, Hodgkins LLC made a bona fide gift of 17,885 shares to a donor-advised fund on November 5, 2026, pursuant to the same plan. Ed Hallen is identified as a director and 10% owner; the reported shares were held through the trust and LLC.
Insider Trade Summary 10b5-1
Net Seller: 98,782 shares
Net Sell
5 txns
Insider
Hallen Ed
Role
Director, 10% Owner
Sold
98,782 shs ($2.11M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Series A Common Stock F1, F2, F3 | 32,663 | $21.35 | $697K |
| Sale | Series A Common Stock F1, F4, F3 | 6,504 | $20.71 | $135K |
| Sale | Series A Common Stock F1, F5, F6 | 45,558 | $21.52 | $980K |
| Sale | Series A Common Stock F1, F7, F6 | 14,057 | $21.07 | $296K |
| Gift | Series A Common Stock F8, F6 | 17,885 | $0.00 | $0.00 |
Holdings After Transaction:
Series A Common Stock — 16,123 shares (Indirect, By Hodgkins Trust);
Series A Common Stock — 292,746 shares (Indirect, By Hodgkins LLC)
Footnotes (8)
- F1. These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.00 to $21.99 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. Shares are owned directly by Hodgkins Trust for the benefit of the Reporting Person and the Reporting Person's family, and of which the trustee is an independent institution. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.62 to $20.99 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.15 to $22.14 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. Shares held by Hodgkins LLC, of which the Reporting Person serves as manager. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.97 to $21.14 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. Represents a bona fide gift of 17,885 shares of stock from Hodgkins LLC, of which Reporting Person serves as manager, to a donor-advised fund pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026.
Key Figures
Hodgkins Trust shares sold: 32,663 shares at a weighted-average price of $21.35 per share
Hodgkins Trust shares sold: 6,504 shares at a weighted-average price of $20.71 per share
Hodgkins LLC shares sold: 45,558 shares at a weighted-average price of $21.52 per share
+2 more
5 metrics
Hodgkins Trust shares sold
32,663 shares at a weighted-average price of $21.35 per share
November 5, 2026; multiple transactions
Hodgkins Trust shares sold
6,504 shares at a weighted-average price of $20.71 per share
November 5, 2026; multiple transactions
Hodgkins LLC shares sold
45,558 shares at a weighted-average price of $21.52 per share
November 5, 2026; multiple transactions
Hodgkins LLC shares sold
14,057 shares at a weighted-average price of $21.07 per share
November 5, 2026; multiple transactions
Shares gifted by Hodgkins LLC
17,885 shares
Gift to a donor-advised fund on November 5, 2026
Key Terms
Rule 10b5-1 trading plan, weighted average price, donor-advised fund, Section 16 beneficial ownership
4 terms
Rule 10b5-1 trading plan regulatory
"pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
donor-advised fund financial
"to a donor-advised fund"
A donor-advised fund is a charitable giving account that lets an individual or family deposit cash, stock, or other assets now, get an immediate tax benefit, and then recommend grants to charities over time. Think of it like a private charitable bucket you control without running a charity yourself; investors care because it’s a tax-efficient way to give appreciated securities, can change when and how donated shares enter the market, and affects personal and corporate tax planning.
Section 16 beneficial ownership regulatory
"disclaims Section 16 beneficial ownership"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were the price ranges for the KVYO sales by Hodgkins Trust and Hodgkins LLC?
Hodgkins Trust's reported sale prices ranged from $21.00 to $21.99 and from $20.62 to $20.99 per share. Hodgkins LLC's reported sale prices ranged from $21.15 to $22.14 and from $20.97 to $21.14 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
